Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Jun 01, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000021.pdf 0001237899-20-000021.xls
May 29, 2020	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-20-067752.pdf 0001104659-20-067752.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
May 29, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001140361-20-012718.pdf 0001140361-20-012718.xls
May 29, 2020	SC 13D/A	An amendment to a SC 13D filing	View HTML 0001140361-20-012717.pdf 0001140361-20-012717.xls
May 28, 2020	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	View HTML 0001047469-20-003238.pdf 0001047469-20-003238.xls
May 26, 2020	FWP	FWP	View HTML 0001104659-20-065591.pdf
May 26, 2020	FWP	FWP	View HTML 0001104659-20-065593.pdf
May 26, 2020	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	View HTML 0001047469-20-003194.pdf 0001047469-20-003194.xls
May 22, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000061.pdf 0001708138-20-000061.xls
May 22, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000062.pdf 0001708138-20-000062.xls

Data provided by Kaleidoscope.

Investors & Media